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Introduction
It was long considered very difficult, if not impossible, for atopic allergens to penetrate normal skin because the skin was considered to be impermeable to high-molecular-weight, hydrophilic proteins. 1 However, this notion has always been challenged by clinical observations. Contact urticaria occurs a few minutes after putting on latex gloves in a latex-sensitized patient. 2 Protein contact dermatitis, observed in butchers, can be reproduced using meat proteins. 3 Atopic patch tests to protein allergens are positive (clinical dermatitis), even when carried out on normal skin of atopic dermatitis (AD) patients. 4 Moreover, proliferative responses of memory T cell to allergens are preferentially detected in cutaneous lymphocyte antigen + T cells in AD patients, but not asthma patients. 5 The percentage of type 2 cytokine-producing cells is remarkably increased among the cutaneous lymphocyte antigen + subset, whereas the percentage of type 1 cytokineproducing cells is decreased. 6 The last two studies suggest that these cells were primed or reactivated in the cutaneous immune system. In recent years, the demonstration that mutation in the filaggrin gene is a predisposing factor for AD has convinced many investigators that epicutaneous (EC) sensitization with protein antigen (Ag) is one of the important routes of allergen sensitization for AD. 7 Methodology of murine models of EC sensitization with protein Ag
Our laboratory developed a murine protein-patch model to study EC sensitization with protein Ag approximately 20 years ago. 8 In this model, ovalbumin (OVA) solution is first applied to a 1-cm 2 gauze on patches or discs in Finn chambers, which were applied to shaved backs without prior tape-stripping. The patches were renewed either every day for 5 successive days or on Day 4. Our method emphasizes mimicking physiologic conditions with repeated exposure, without disruption of the skin barrier and without the use of adjuvants. Subsequently, Spergel et al 9 reported another EC sensitization model in 1998. Spergel et al 9 also used a l Â l cm patch of sterile gauze secured to the back skin, but with two modifications. First, they performed tape-stripping before application of the patch to disrupt the skin barrier. Second, one patch was placed for 1 week before being removed. Two weeks later, an identical patch was reapplied to the same skin site. Thus, one mouse had a total of three 1-week exposures to the patch separated by a 2-week interval. 
Mechanisms of EC sensitization with protein Ag
The role of the skin barrier Protein Ag sensitization via the EC route needs to first overcome the epidermal barrier. The barrier function of the skin has the following three elements: the stratum corneum (air-liquid barrier); the tight junction (liquid-liquid barrier); and the Langerhans cell (LC) network (immunologic barrier). 26 Skin barriers face harsh challenges in modern lifestyles with regular use of soap in bathing and long-term exposure to air conditioned or heated environments. This might account, in part, for the progressive increase in atopic diseases in industrialized countries in the past few decades. For the stratum corneum, filaggrin mutations have been repeatedly demonstrated to be a predisposing factor for AD. 7, 27 An altered stratum corneum barrier, enhanced allergen sensitization, and spontaneous development of dermatitis have all been demonstrated in filaggrin-deficient mice. 28, 29 Filaggrin loss-of-function mutations have further been shown to be associated with enhanced IL-1 expression in the stratum corneum of patients with AD and in filaggrin-deficient mice. 30 The contribution of a stratum corneum deficiency to EC sensitization with protein Ag is further supported by the clinical observation of an association of genes controlling desquamation, such as serine protease inhibitor and stratum corneum chymotryptic enzyme, with the development of AD. 31, 32 For tight junctions, a polymorphism in the claudin-1 gene, which is one of the major components of epidermal tight junctions, was recently reported to be associated with AD. 33 Interestingly, cutaneous barrier perturbation can not only stimulate proinflammatory cytokine production in the epidermis, but also induce LC activation with the dendrites penetrating the tight junction barrier and facilitating capture of Ag by LCs. 21, 34 
The role of Toll-like receptor ligands and other innate elements
The effects of various Toll-like receptor TLR ligands on the Th responses induced by EC sensitization with protein Ag have been investigated. TLR2 is important for the Th1 response, but not the Th2 response, because (interferon) IFN-g production (Th1 response) by splenocytes after restimulation and anti-OVA IgG2a Ab levels are impaired in TLR2-deficient mice, whereas the Th2 cytokine production and anti-OVA IgE Ab level are comparable to wild-type controls. 42 In contrast, the Th1 and Th2 responses induced by EC sensitization with protein Ag is TLR4-independent. 43 Ptak et al 44 further showed that EC sensitization with protein antigen in the presence of TLR4 ligand induced contrasuppressor cells that can reverse skin-induced suppression of Th1-mediated contact sensitivity.For CD8 T cells, topical co-administration of TLR9 ligand with protein Ag promotes the generation of cytotoxic T cells in EC sensitization, whereas ligands for TLR2, TLR3, or TLR4 have no effect. 25, 43, 45 Overall, the predominant Th2 response induced in EC sensitization with protein Ag is TLR-independent; however, TLR9 ligand can promote cross-priming in EC sensitization to CD8 T cells. Other mediators in innate immunity have been reported to modulate the immune responses induced by EC sensitization with protein Ag. Cyclooxygenase-2 suppresses the induced Th2 response, whereas agonizing prostaglandin D2 receptor (CRTH2) has no effect on the induced immune responses as evidenced by the observation that CRTH2-deficient mice showed comparable responses with wild-type mice. 46 
The role of antigen characteristics
The same proteins typically behave as allergens across the human population. It is still not clear which factors determine the allergenicity of proteins within the natural environment. The current theory focuses on a common structural motif and enzymatic properties. 59 Many atopic allergens possess enzyme activities. It has been shown that Der p1, the major allergen in house dust mite, facilitates transepithelial allergen delivery by disruption of tight junctions, with occludin serving as a functional target of peptidase activity. 60, 61 The effects of natural allergens on DCs have been investigated. The proteolytic activity of the major dust mite allergen conditioned DCs to produce less IL-12, thus directing DCs to induce Th2 development. 62 Aqueous birch pollen enhances the migratory capacity of DCs and prepare DCs for Th2 attraction by modulating the expression of chemokines and chemokine receptors. 63 House dust mite extract stimulated a robust production of cysteinyl leukotrienes from pulmonary DCs via dectin-2 recognition. 64 Natural allergens also have effects on epithelial cells. Natural allergens induce proinflammatory cytokines from respiratory epithelial cells and delayed epidermal permeability barrier recovery, both mediated by activation of PAR-2. 65, 66 Most importantly, Derp 2 has been shown to have structural and functional homology with MD-2 (a protein associated with TLR4 on the cell surface), facilitating signaling through direct interaction with the TLR4 complex, and reconstituting LPS-driven TLR4 signaling in the absence of MD-2. 67 Thus, house dust mite extract has Th2 adjuvant and tolerogenic activities in intranasal sensitization. 68 Because EC sensitization with protein Ag has been shown to be TLR-4-independent, whether or not all or part of the above-mentioned mechanisms operate in EC sensitization needs further investigation and remains largely unknown at present.
Establishment of murine models of AD, asthma and food allergy by EC sensitization with protein Ag
Spergel et al 9 first demonstrated that by thrice-repeating EC OVA patch application, an AD-like cutaneous inflammation could be induced. The cutaneous inflammation was characterized by infiltration of T cells, eosinophils, and neutrophils, and by local expression of mRNA for IL-4, IL-5, and IFN-g. Later, by using IL-4, IL-5 and IFN-g knockout mice, they showed that Th2 and Th1 cytokines play important roles in AD-like dermatitis. 69 Spergel et al 9 also extended the EC route as a sensitization method for asthma, showing a single exposure of EC-sensitized mice to aerosolized OVA induced eosinophils in the bronchoalveolar lavage fluid and airway hypersensitivity to intravenous methacholine. Later, He et al 19 suggested that
Th17 cells play an important role in driving airway inflammation after inhalation challenge. The investigation of underlying mechanisms of the progression from AD to asthma revealed that thymic stromal lymphopoietin overexpressed by skin keratinocytes is the systemic driver of this bronchial hyper-responsiveness. 70 76 Senti et al 77 first developed EC immunotherapy in humans. By applying four allergen-containing patches to the patient's upper arm at weekly intervals,they reported that patients receiving EC immunotherapy showed significantly decreased scores in a nasal provocation test in 2009. Later, a French company (DBV Technologies) developed a new EC delivery system, called Viaskin, that could promote diffusion of allergens toward skin without any skin preparation or adjuvant. 78 DBV Technologies developed a new regimen to apply the EC delivery system for 48 hours/week for eight times and showed that in mice sensitized to the four allergens tested, EC immunotherapy was as efficient as subcutaneous immunotherapy. 78 Dupont et al 79 reported that EC immunotherapy was safe, well tolerated, and exhibited a clear trend toward clinical efficacy for children with cow's milk allergy. EC immunotherapy could also block the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice. 80 The underlying mechanisms might be that after protein Ag is applied repeatedly with the EC delivery system, specific local and systemic responses are downregulated in association with the induction of regulatory T cells. 81 
Conclusions and future perspectives
At present, we have learned that EC sensitization with protein Ag is an important route for AD, which induces predominant Th2, marginal Th1, and significant Th17 and Treg responses. Some modulating factors have been identified, including cytokines, T cell receptor signaling, complement, and lipid mediators (summarized in Figure 1 ). However, an understanding of the mechanisms of EC sensitization with protein Ag is just beginning. Some basic questions remain. For example, why does EC sensitization with protein and hapten induce such different responses? Why does EC sensitization with protein Ag induce differential responses in human atopy and nonatopy? EC sensitization with protein antigen and with hapten are major routes for atopic dermatitis and allergic contact dermatitis, respectively. Haptens are small chemicals that penetrate skin easily and need to react covalently with carrier proteins before being recognized as immunogens by the immune system. Protein antigens are large hydrophilic molecules that penetrate skin with difficulty. Thus, knowledge obtained from murine contact hypersensitivity model and human allergic contact dermatitis could not be applied to EC sensitization with protein antigen directly. The clinical importance as well as its therapeutic potential emphasizes the demand for EC sensitization with protein Ag to be intensively investigated. 
